Status:
COMPLETED
The Effectiveness of Topical Sesame Oil in Preventing Phlebitis at IV Cannula Sites in Adults
Lead Sponsor:
National Heart Centre Singapore
Conditions:
Phlebitis
Thrombophlebitis
Eligibility:
All Genders
21-80 years
Phase:
NA
Brief Summary
The goal of this randomised controlled trial is to determine the effectiveness of topical sesame oil in preventing phlebitis at peripheral intravenous (IV) cannula sites in adult patients within a car...
Detailed Description
The goal of this randomised controlled trial is to determine the effectiveness of topical sesame oil in preventing phlebitis at peripheral intravenous (IV) cannula sites in adult patients within a car...
Eligibility Criteria
Inclusion
- Age 21-80
- Patients must speak and understand either English or Mandarin
- Patients who possess a peripheral IV cannula
- IV cannula must have been inserted for less than 12 hours
- IV cannula must be on an upper extremity
- IV cannula must be patent
- IV cannula sites must show no signs of redness, swelling, pain, a palpable venous cord or pyrexia
- Patient must be admitted to a cardiology ward in the National Heart Centre Singapore
Exclusion
- Patients who do not speak or understand either English or Mandarin
- Patients with venous insufficiency
- Patients with coagulopathies
- Patients with cognitive or sensory impairments that would inhibit their ability to rate their pain via a Numerical Rating Scale (NRS)
- Patients who are receiving medications that might interfere with timely reporting of adverse events (eg. medications that cause severe drowsiness)
- Patients who report allergies to sesame or liquid paraffin oil
- IV cannulas that were inserted and used for resuscitation
- Patients with existing skin conditions that cause their skin to be red or swollen and might affect the investigators ability to assess for phlebitis
- Patients who possess more than one peripheral IV cannula will only be included in the study once. All subsequent IV cannula insertions will be excluded.
Key Trial Info
Start Date :
April 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 21 2022
Estimated Enrollment :
263 Patients enrolled
Trial Details
Trial ID
NCT06216522
Start Date
April 12 2022
End Date
October 21 2022
Last Update
February 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Heart Centre Singapore
Singapore, Singapore, 169609